CHL [CHINA MOBILE] 6-K: (Original Filing)
[Number Page 1.1 Announcement, dated December 4, 2013 A-1 -2-]
BORN [CHINA NEW BORUN] 6-K: (Original Filing)
[CHINA NEW BORUN CORPORATION Notice is hereby given that China New Borun Corporation, a Cayman Islands company (the “Company”), will hold its annual general meeting of shareholders at 10:00 a.m., local time, on January 10, 2014 (the “Annual General Meeting”) at the Company's corporate office located at Bohai Industrial Park (Yangkou Town), Shouguang, Shandong 262715, People's Republic of China, to] [CHINA NEW BORUN CORPORATION PROXY STATEMENT General Our board of directors is soliciting proxies for the annual general meeting of shareholders to be held on January 10, 2014 at 10:00 a.m., local time, or at any adjournment or postponement thereof (the “Annual General Meeting”). The Annual General Meeting will be held at our corporate office located at Bohai Industrial Park] [CHINA NEW BORUN CORPORATION (incorporated in the Cayman Islands with limited liability) FORM OF PROXY FOR THE ANNUAL GENERAL MEETING to Be Held on January 10, 2014 (or any adjourned or postponed meeting thereof) 1 2 (Name) Address) , par value US$0.001 per share, of China New Borun Corporation (the “Company”), hereby appoint the Chairman of the Annual General Meeting] [] [FORM 6-K China New Borun Corporation Bohai Industrial Park Yangkou Town Shouguang, Shandong 262715 People’s Republic of China x Form 20-F o Form 40-F o o China New Borun Corporation Terence Chen Chief Financial Officer 2 Notice of Annual General Meeting Proxy Statement]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-3: (Original Filing)
[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China (8629) 8819-3188] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our reportted April 1, 2013 relating to thensolidated financial statements, which appears inystar Bio-Pharmaceuticalmpanys Annual Report on Form 10-K for the year ended December 31, 2012.] [Consent of Independent Registered Public Accounting Firm Wensent to theorporation by reference in this Registration Statement on Form S-3 and related Prospectus ofystar Bio-Pharmaceuticalmpany of our reportted March 30, 2012 relating to the December 31, 2011nsolidated financial statements appearing in the Annual Report on Form 10-K ofystar Bio-Pharmaceuticalmpany for the year ended December 31, 2012,]
KUTV [Ku6 Media] 6-K: (Original Filing)
[Ku6 Media Announces Appointment of Chief Financial Officer Beijing, China (December 4, 2013) - Ku6 Media Co., Ltd. (Ku6 Media or the Company, NASDAQ: KUTV), a leading internet video company in China, focusing on User Generated Content (UGC), today announced that Mr. Frank Feng, the Acting Chief Financial Officer of Ku6 Media, has been appointed as the Chief Financial Officer]
CHL [CHINA MOBILE] 6-K: Number Page 1.1 Announcement, dated December 4, 2013
[Number Page 1.1 Announcement, dated December 4, 2013 A-1 -2-]
BORN [CHINA NEW BORUN] 6-K: CHINA NEW BORUN CORPORATION Notice is hereby given
[CHINA NEW BORUN CORPORATION Notice is hereby given that China New Borun Corporation, a Cayman Islands company (the “Company”), will hold its annual general meeting of shareholders at 10:00 a.m., local time, on January 10, 2014 (the “Annual General Meeting”) at the Company's corporate office located at Bohai Industrial Park (Yangkou Town), Shouguang, Shandong 262715, People's Republic of China, to] [CHINA NEW BORUN CORPORATION PROXY STATEMENT General Our board of directors is soliciting proxies for the annual general meeting of shareholders to be held on January 10, 2014 at 10:00 a.m., local time, or at any adjournment or postponement thereof (the “Annual General Meeting”). The Annual General Meeting will be held at our corporate office located at Bohai Industrial Park] [CHINA NEW BORUN CORPORATION (incorporated in the Cayman Islands with limited liability) FORM OF PROXY FOR THE ANNUAL GENERAL MEETING to Be Held on January 10, 2014 (or any adjourned or postponed meeting thereof) 1 2 (Name) Address) , par value US$0.001 per share, of China New Borun Corporation (the “Company”), hereby appoint the Chairman of the Annual General Meeting] [] [FORM 6-K China New Borun Corporation Bohai Industrial Park Yangkou Town Shouguang, Shandong 262715 People’s Republic of China x Form 20-F o Form 40-F o o China New Borun Corporation Terence Chen Chief Financial Officer 2 Notice of Annual General Meeting Proxy Statement]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT
[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China (8629) 8819-3188] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our reportted April 1, 2013 relating to thensolidated financial statements, which appears inystar Bio-Pharmaceuticalmpanys Annual Report on Form 10-K for the year ended December 31, 2012.] [Consent of Independent Registered Public Accounting Firm Wensent to theorporation by reference in this Registration Statement on Form S-3 and related Prospectus ofystar Bio-Pharmaceuticalmpany of our reportted March 30, 2012 relating to the December 31, 2011nsolidated financial statements appearing in the Annual Report on Form 10-K ofystar Bio-Pharmaceuticalmpany for the year ended December 31, 2012,]
KUTV [Ku6 Media] 6-K: Ku6 Media Announces Appointment of Chief Financial Officer
[Ku6 Media Announces Appointment of Chief Financial Officer Beijing, China (December 4, 2013) - Ku6 Media Co., Ltd. (Ku6 Media or the Company, NASDAQ: KUTV), a leading internet video company in China, focusing on User Generated Content (UGC), today announced that Mr. Frank Feng, the Acting Chief Financial Officer of Ku6 Media, has been appointed as the Chief Financial Officer]
CXDC [China XD Plastics Co] 8-K: (Original Filing)
[China XD Plastics Announces Outcome of 2013 Annual Shareholders Meeting HARBIN, China, Dec. 4, 2013 /PRNewswire-FirstCall/ -- China XD Plastics Company Limited (NASDAQ: CXDC, “China XD Plastics” or the “Company”), one of China’s leading specialty chemical players engaged in the development, manufacture and sale of modified plastics primarily for automotive applications, today announced that the Company’s shareholders voted upon all] []
